Esperion Therapeutics ESPR Other Inventory, Net
Other Inventory, Net at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryValuationReserves.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's other inventory, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's other inventory, net?
- Esperion Therapeutics (ESPR) reported other inventory, net of $16.4M in Q1 2026.
- How has Esperion Therapeutics's other inventory, net changed year-over-year?
- Esperion Therapeutics's other inventory, net increased by 272.7% year-over-year, from $4.4M to $16.4M.
- What is the long-term trend for Esperion Therapeutics's other inventory, net?
- Over 2 years (2023 to 2025), Esperion Therapeutics's other inventory, net has grown at a 21.8% compound annual growth rate (CAGR), from $3.1M to $4.6M.
- What does other inventory, net mean?
- This represents the value of miscellaneous inventory items held by the company, net of any valuation reserves or allowances for obsolescence. It captures secondary stock categories that are not classified under primary raw materials or finished goods. Monitoring this helps assess the efficiency of inventory management and potential risks of asset impairment.